Skip to main content

GRFS · Grifols SA · Webcasts, Transcripts & Audio

Track GRFS — free
$8.15 -0.05 (-0.61%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$5.55B
Shares
680.58M
Volume · Nov 20 848.3K Avg daily vol (3M) 622.34K

Grifols SA Webcasts

Earnings calls, investor updates, investor days and conferences for Grifols SA (GRFS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q3
2026-11-02
Grifols SA (GRFS) Q3 2026 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-07-28
Grifols SA (GRFS) Q2 2026 Earnings Call Transcript
Confident tone Albumin stabilization in China Plasma sourcing and self-sufficiency Financial profile and cash generation
No reported figures on file
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Grifols SA (GRFS) Q1 2026 Earnings Call Transcript
Positive tone Albumin in China headwinds Egypt plasma platform and global sourcing optimization Balance sheet and refinancing
No reported figures on file
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Grifols SA (GRFS) Q4 2025 Earnings Call Transcript
Confident tone Egypt and Canada self-sufficiency projects Cash flow generation and deleveraging Immunoglobulin growth and market share
No reported figures on file
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Grifols SA (GRFS) Q3 2025 Earnings Call Transcript
Positive tone Free cash flow generation Margin expansion and EBITDA Fibrinogen pipeline
No reported figures on file
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-29
Grifols SA (GRFS) Q2 2025 Earnings Call Transcript
Confident tone Commercial growth / Biopharma momentum Free cash flow & deleveraging Pipeline execution & fibrinogen launch
No reported figures on file
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Grifols SA (GRFS) Q1 2025 Earnings Call Transcript
Positive tone Q1 2025 Financial Performance Albumin Market and Phasing Fibrinogen Launch
No reported figures on file
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Date not confirmed
Grifols SA (GRFS) Q1 2024 Earnings Call Transcript
Positive tone Free cash flow generation Debt management and deleveraging Biopharma and plasma business momentum
No reported figures on file
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Date not confirmed
Grifols SA (GRFS) Q4 2023 Earnings Call Transcript
No reported figures on file
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Date not confirmed
Grifols SA (GRFS) Q3 2023 Earnings Call Transcript
No reported figures on file
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Date not confirmed
Grifols SA (GRFS) Q2 2023 Earnings Call Transcript
No reported figures on file
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Date not confirmed
Grifols SA (GRFS) Q1 2023 Earnings Call Transcript
No reported figures on file
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Date not confirmed
Grifols SA (GRFS) Q4 2022 Earnings Call Transcript
No reported figures on file
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Date not confirmed
Grifols SA (GRFS) Q3 2022 Earnings Call Transcript
No reported figures on file
Audio Transcript Slides 8-K10-Q
Showing 1–14 of 14 webcasts
Key facts CIK 1438569 CUSIP 398438408 13F (30d) 181 filings 153 filers Visit website Investor relations